Scan to Download
One powerful score. Smarter investment decisions.
CG Oncology Inc
CGON39.840USD
-0.300-0.75%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
39.840USD+39.840After-hours (ET)
3.12BMarket Cap
LossP/E TTM
CG Oncology Inc
39.840
-0.300-0.75%
You can access the annual and quarterly cash flow statements of CG Oncology Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-144.32%-38.89M
-73.44%-27.96M
-12.55%-29.28M
-28.65%-20.66M
-29.82%-15.92M
-49.45%-16.12M
-225.72%-26.01M
-135.19%-16.06M
---12.26M
---10.79M
---7.99M
---6.83M
Net income from continuing operations
-114.69%-43.81M
-119.14%-41.43M
-103.47%-34.45M
-97.31%-31.80M
-73.39%-20.41M
-62.73%-18.90M
-95.36%-16.93M
-92.04%-16.12M
---11.77M
---11.62M
---8.67M
---8.39M
Operating gains losses
1880.95%416.00K
2128.57%156.00K
500.00%24.00K
-100.00%0.00
320.00%21.00K
75.00%7.00K
0.00%4.00K
0.00%4.00K
--5.00K
--4.00K
--4.00K
--4.00K
Other non-cash items
102.52%40.00K
4.73%-2.36M
78.70%-469.00K
143.27%1.25M
-45.77%-1.59M
-780.22%-2.48M
-1861.60%-2.20M
-2800.00%-2.89M
---1.09M
--364.00K
--125.00K
--107.00K
Change in working capital
-184.45%-2.87M
188.09%8.66M
105.58%469.00K
126.46%4.90M
1644.62%3.40M
951.40%3.01M
-2351.74%-8.40M
65.80%2.16M
--195.00K
--286.00K
--373.00K
--1.30M
-Change in receivables
-628.89%-238.00K
-141.11%-217.00K
--436.00K
---644.00K
4600.00%45.00K
---90.00K
----
----
---1.00K
----
----
----
-Change in inventory
---380.00K
----
----
----
----
----
----
----
----
----
----
----
-Change in prepaid expenses
75.64%-105.00K
-17.60%997.00K
82.63%-982.00K
59.59%-198.00K
76.84%-431.00K
327.87%1.21M
-2624.11%-5.65M
-168.92%-490.00K
---1.86M
---531.00K
--224.00K
--711.00K
-Change in other current assets
---7.00K
2300.00%22.00K
-6.06%-35.00K
---41.00K
-100.00%0.00
---1.00K
---33.00K
--0.00
--13.00K
--0.00
--0.00
--0.00
-Change in other current liabilities
--9.00K
----
----
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-144.32%-38.89M
-73.44%-27.96M
-12.55%-29.28M
-28.65%-20.66M
-29.82%-15.92M
-49.45%-16.12M
-225.72%-26.01M
-135.19%-16.06M
---12.26M
---10.79M
---7.99M
---6.83M
Investing cash flow
Net cash from continuing investing activities
9800.00%97.00K
0.00%14.00K
33.33%16.00K
--209.00K
83.33%-1.00K
133.33%14.00K
--12.00K
----
---6.00K
--6.00K
--0.00
---1.00K
Capital expenditures
--97.00K
0.00%14.00K
33.33%16.00K
--209.00K
----
133.33%14.00K
--12.00K
----
----
--6.00K
--0.00
----
Net cash flow from disposal of fixed assets
9800.00%97.00K
0.00%14.00K
33.33%16.00K
--209.00K
83.33%-1.00K
133.33%14.00K
--12.00K
----
---6.00K
--6.00K
--0.00
---1.00K
Net cash flow from business transactions
---21.97M
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from investment products
-65.29%11.11M
106.68%2.42M
47.39%-161.75M
-34.40%11.11M
119.83%32.00M
-135.04%-36.22M
-290.64%-307.43M
130.62%16.94M
---161.39M
--103.36M
---78.70M
---55.34M
Net cash flow from other investing activities
--26.00M
---1.00M
---25.00M
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
-52.99%15.04M
103.88%1.41M
39.25%-186.77M
-35.64%10.90M
119.83%32.01M
-135.05%-36.23M
-290.66%-307.44M
130.62%16.94M
---161.39M
--103.36M
---78.70M
---55.34M
Financing cash flow
Cash flow from continuous financing activities
2409.00%54.37M
-840.00%-296.00K
-99.89%450.00K
7833.26%223.41M
-97.95%2.17M
100.26%40.00K
52735.03%402.66M
-105.10%-2.89M
--105.88M
---15.22M
---765.00K
--56.70M
Net cash flow from debt Issuance/repayment
----
----
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
56.18%-365.00K
---1.00K
---61.00K
---15.39M
---833.00K
----
Net cash flow from common stock issuance/repurchase
--49.00M
----
-100.00%0.00
--223.06M
--0.00
--0.00
--406.41M
----
--0.00
--0.00
--0.00
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
-100.00%0.00
----
----
-100.00%2.00K
--104.63M
----
----
--56.55M
Proceeds from stock option exercised by employees
135.30%5.10M
-75.32%19.00K
--682.00K
36.02%355.00K
36.55%2.17M
-53.33%77.00K
-100.00%0.00
76.35%261.00K
--1.59M
--165.00K
--68.00K
--148.00K
Net cash flow from other financing activities
--270.00K
-751.35%-315.00K
93.15%-232.00K
100.00%0.00
100.00%0.00
---37.00K
---3.39M
---3.15M
---270.00K
--0.00
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
2409.00%54.37M
-840.00%-296.00K
-99.89%450.00K
7833.26%223.41M
-97.95%2.17M
100.26%40.00K
52735.03%402.66M
-105.10%-2.89M
--105.88M
---15.22M
---765.00K
--56.70M
Net cash flow
Beginning cash balance
-41.87%14.62M
-46.47%41.47M
3009.94%257.07M
322.57%43.41M
-67.76%25.16M
11078.64%77.47M
-90.62%8.27M
-89.03%10.27M
--78.04M
--693.00K
--88.14M
--93.61M
Current period cash flow changes
67.21%30.52M
48.68%-26.85M
-411.55%-215.60M
10745.59%213.66M
126.94%18.25M
-167.63%-52.31M
179.13%69.20M
63.30%-2.01M
---67.77M
--77.35M
---87.45M
---5.47M
Ending cash balance
3.99%45.15M
-41.87%14.62M
-46.47%41.47M
3009.94%257.07M
322.57%43.41M
-67.76%25.16M
11078.64%77.47M
-90.62%8.27M
--10.27M
--78.04M
--693.00K
--88.14M
Free cash flow
---38.99M
-73.38%-27.97M
-12.56%-29.29M
-29.95%-20.87M
----
-49.50%-16.13M
-225.87%-26.02M
---16.06M
----
---10.79M
---7.99M
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
